Try our Advanced Search for more refined results

September 16, 2020

Kendall v. Odonate Therapeutics, Inc. et al

Track this case

Case Number:

3:20-cv-01828

Court:

California Southern

Nature of Suit:

Securities/Commodities

Multi Party Litigation:

Class Action

Judge:

Marilyn L. Huff

Firms

Companies

Sectors & Industries:

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. January 12, 2022

    Court OKs Pharma Investors' $12.7M Deal Over Drug Trial

    A California federal judge granted preliminary approval of the $12.7 million settlement between Odonate Therapeutics Inc. and investors on Wednesday, ending a class action that accused the pharmaceutical company of misleading investors by concealing information on a trial for a chemotherapy agent in development.

1 other articles on this case. View all »

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login